ELA026, a monoclonal antibody targeting signal regulatory protein-α/β1/γ, rapidly controls inflammation and improves 2-month survival in treatment-naïve malignancy-associated hemophagocytic lymphohistiocytosis Meeting Abstract
| Authors: | Maiti, A.; Daver, N.; Johnson, W. T.; Goyal, G.; Broome, C. M.; Gohil, S.; Van Laar, J.; Jimenez, J. L.; McCall, D.; Lane, H.; Kim, B.; Panicker, S.; Patou, G.; Moore, S.; Mangal, B.; Covert, K.; Parry, G. C.; Dong, K.; Allen, C.; Iyer, S. P. |
| Abstract Title: | ELA026, a monoclonal antibody targeting signal regulatory protein-α/β1/γ, rapidly controls inflammation and improves 2-month survival in treatment-naïve malignancy-associated hemophagocytic lymphohistiocytosis |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 805 |
| End Page: | 806 |
| Language: | English |
| ACCESSION: | WOS:001412608600005 |
| DOI: | 10.1182/blood-2024-204230 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Hybrid event -- Source: Wos |
